At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
"Walk With Ease"other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Walk With Ease Program For Patients With Systemic Lupus Erythematosus
In Brief
A clinical study evaluating "Walk With Ease" for Systemic Lupus Erythematosus. Completed, enrolled 76 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effects of "Walk With Ease", a moderate-intensity exercise program, on pain, stiffness, and fatigue caused by lupus. Participants will receive a copy of the "Walk With Ease" workbook. The book provides guidance about walking safety as well as how to start, build-up, and maintain a walking program. Participants will complete questionnaires assessing their symptoms before and after completing the six-week program.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Lupus Erythematosus
CountriesUnited States
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartMar 2016
Primary CompletionApr 2018
Study CompletionAug 2018
TodayJul 2026
First PostedDec 15, 2015
Enrollment StartMar 1, 2016
Primary CompletionApr 1, 2018
Study CompletionAug 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 10.5 years ago
Interventions
"Walk With Ease"other
Six-week walking program